Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 CAD | +1.01% | +1.01% | -25.51% |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 22/07/12 | |
Bruce G. Cousins
DFI | Director of Finance/CFO | 63 | 02/05/21 |
Amanda Malone
COO | Chief Operating Officer | - | 31/07/12 |
Mark M. Kowalski
CTO | Chief Tech/Sci/R&D Officer | 69 | 17/05/23 |
Vik Peck
IRO | Public Communications Contact | - | - |
Adam Peeler
IRC | Investor Relations Contact | - | - |
Murray Webb
PRN | Corporate Officer/Principal | - | 31/03/17 |
Ash Bassett
PRN | Corporate Officer/Principal | - | - |
Paul A. Brennan
PRN | Corporate Officer/Principal | - | 31/05/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Geyer
BRD | Director/Board Member | 61 | 13/01/13 |
John Montalbano
FOU | Founder | 59 | 13/01/13 |
Richard Glickman
BRD | Director/Board Member | 65 | 08/03/21 |
Simon Pimstone
CHM | Chairman | 56 | 13/01/13 |
Founder | - | 22/07/12 | |
Michael Wilmink
BRD | Director/Board Member | - | 13/01/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,622,553 | 33,087,005 ( 92.88 %) | 0 | 92.88 % |
Company contact information
Eupraxia Pharmaceuticals, Inc.
2067 Cadboro Bay Road Suite 201
V8R 5G4, Victoria
+
http://www.eupraxiapharmaceuticals.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.51% | 104M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- EPRX Stock
- Company Eupraxia Pharmaceuticals Inc.